Glucagon-like peptide 1 receptor agonists in chronic disease management beyond diabetes

Researchers reviewed human studies of GLP-1 receptor agonists, medicines that copy a natural gut hormone. The studies included people with obesity, heart disease, fatty liver disease, and other long-term conditions. These medicines often helped with weight loss and blood sugar, and some studies found improvements in heart-related outcomes. Nausea, vomiting, and diarrhea were common side effects, and benefits varied by drug and condition.

What this means for you: These medicines may help some people beyond diabetes, but they are prescription treatments, not general-purpose longevity products. Do not buy them or use them without medical guidance, because long-term benefits and risks are still unclear for several conditions.